Pieris AG Appoints Chief Scientific Officer
Pieris AG announced that Laurent Audoly, Ph.D., has joined the company as Chief Scientific Officer, effective immediately. Dr. Audoly, most recently biologics Research Site Lead at Merck & Co. Inc., brings both pharma and biotech experience, with extensive expertise in therapeutic protein drug development.
Over the course of his career, Dr. Audoly has held research and managerial positions of increasing responsibility, first as Senior Research Scientist, Department of Inflammation, at Pfizer Inc. and then as Senior Research Fellow, Department of Pharmacology, at Merck & Co. Inc. He then joined MedImmune Inc. as Director R&D Inflammation and most recently held the position at Merck and Co. Inc. as Biologics Research Site Lead. He holds a degree in Chemistry from the University of South Florida and a Ph.D. in Pharmacology from Vanderbilt University. Following his studies, he completed post-doctoral research at Duke University and the University of North Carolina.
Other news from the department people
